跳轉至內容
Merck
全部照片(4)

Key Documents

461350

Sigma-Aldrich

1-Boc-4-哌啶酮

98%

同義詞:

N-Boc-4-哌啶酮, 丁基4-氧代-1-哌啶羧酸盐

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C10H17NO3
CAS號碼:
分子量::
199.25
Beilstein:
3650236
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

98%

mp

73-77 °C (lit.)

SMILES 字串

CC(C)(C)OC(=O)N1CCC(=O)CC1

InChI

1S/C10H17NO3/c1-10(2,3)14-9(13)11-6-4-8(12)5-7-11/h4-7H2,1-3H3

InChI 密鑰

ROUYFJUVMYHXFJ-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

1-Boc-4-哌啶酮在合成药物中被用作前体,同时也是合成选择性配体的合成砌块。

應用

1-Boc-4-哌啶酮,一个制药结构单元,可用于合成(3E,5E)-3,5-双(2,5-二甲氧基亚苄基)-1-丁氧基羰基哌啶-4-酮(RL197)。它也可以用于合成含有哌啶环结构的螺吡霉素。

警告

避免接触金属。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

In Ho Kim et al.
Bioorganic & medicinal chemistry letters, 17(5), 1181-1184 (2006-12-27)
A novel series of spirorifamycins was synthesized and their antibacterial activity evaluated both in vitro and in vivo. This new series of rifamycins shows excellent activity against Staphylococcus aureus that is equivalent to rifabutin. However, some compounds of the series
Atsuya Takami et al.
Bioorganic & medicinal chemistry, 12(9), 2115-2137 (2004-04-15)
Several structurally unrelated scaffolds of the Rho kinase inhibitor were designed using pharmacophore information obtained from the results of a high-throughput screening and structural information from a homology model of Rho kinase. A docking simulation using the ligand-binding pocket of
John W Clader et al.
Bioorganic & medicinal chemistry, 12(2), 319-326 (2004-01-16)
Anthranilamide analogues such as 23 are potent and highly selective muscarinic M2 antagonists that also show good oral bioavailability and in vivo activity.
Marlon Cowart et al.
Journal of medicinal chemistry, 47(15), 3853-3864 (2004-07-09)
A new class of agents with potential utility for the treatment of erectile dysfunction has been discovered, guided by the hypothesis that selective D4 agonists are erectogenic but devoid of the side effects typically associated with dopaminergic agents. The lead
Gebhard Thoma et al.
Journal of medicinal chemistry, 47(8), 1939-1955 (2004-04-02)
The chemokine receptor CCR5 plays an important role in inflammatory and autoimmune disorders as well as in transplant rejection by affecting the trafficking of effector T cells and monocytes to diseased tissues. Antagonists of CCR5 are believed to be of

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務